Market Place
Sourcing Support
Sun Pharma signs Definitive Agreement to Acquire Organon
27 Apr 2026 //
BUSINESSWIRE
Glenmark Set To Join Peers In `Semaglutide` Push
02 Mar 2026 //
ECONOMICTIMES
Sun Pharma Receives DCGI Approval For Generic Semaglutide
23 Jan 2026 //
ECONOMICTIMES
Sun Pharma Eyes Obesity Drugs as Growth Driver
28 Dec 2025 //
ECONOMICTIMES
Sun Pharma`s Innovative Drug Sale Surpass Generics for First Time
06 Nov 2025 //
ECONOMICTIMES
Fine, Kaplan And Black Announce Class Action Settlement
03 Oct 2025 //
PR NEWSWIRE
Sun, Taro Ink $200 M Deal to Settle Antitrust Litigation
25 Jul 2025 //
FIERCE PHARMA
Sun Pharma Settles Litigation with Incyte Corp Over Leqselvi
14 Jul 2025 //
ECONOMICTIMES
Sun Pharma gets USFDA nod to market generic medication
10 Feb 2023 //
ECONOMIC TIMES
AbbVie puts up fight against Orilissa generics from Sandoz, Teva and others
31 Oct 2022 //
ENDPTS
Sun Pharma launches generic favipiravir, FluGuard at Rs 35 per tablet
03 Aug 2020 //
EXPRESSPHARMA
Pfizer, Ranbaxy Sued Over Delay Of Generic Lipitor
26 May 2020 //
LAW360
Sun Pharma Raids Covid-19 Antibody Outfit for General Counsel
13 May 2020 //
BLOOMBERG
Safeguarding And Streamlining Pharma Supply Chain: Time For Certified Drugs
08 May 2020 //
FORBES
Sun Pharma announces tie-up for China foray; to develop 8 generic products
16 Aug 2019 //
BUSINESS-STANDARD
Program to boost access to Xelpros in USA
19 Jul 2019 //
THE PHARMALETTER
Uceris (budesonide) : Valeant Pharmaceuticals, Salix Pharmaceuticals vs. Sun Pharmaceutical Industries
13 Dec 2018 //
PATENT LITIGATION
AMITIZA® (lubiprostone) : Sucampo Pharmaceuticals vs. Sun Pharmaceutical
31 Oct 2018 //
PATENT LITIGATION
Oracea (doxycycline) : Galderma Labs vs. Sun Pharmaceutical Industries
19 Oct 2018 //
PATENT LITIGATION
Yonsa (Abiraterone Acetate) : Sun Pharmaceutical vs. Teva Pharmaceuticals
19 Oct 2018 //
PATENT LITIGATION
Xeljanz XR (tofacitinib): Pfizer vs. Sun Pharmaceutical
03 Oct 2018 //
PATENT LITIGATION
Sun Pharma looks to grow complex generics, specialty products biz faster
27 Sep 2018 //
ECONOMIC TIMES
Gleevec antitrust suits against Novartis fall short again in appeals
22 Aug 2018 //
FIERCE PHARMA
MS patent win boosts Novartis’ Gilenya, but helps Celgene, too
13 Jul 2018 //
FIERCE PHARMA
Novartis Wins Patent Fight Over Best-Selling MS Drug
13 Jul 2018 //
BLOOMBERG
Sun 2019 revenues to fall short on U.S. generics price pressure
29 May 2018 //
FIERCE PHARMA
Ultravate® (Halobetasol Propionate) : Sun Pharmaceutical v. Perrigo Company
09 May 2018 //
PATENT LITIGATION
Sun Pharma: Generic, speciality drugs can drive medium-term earnings growth
22 Mar 2018 //
BUSINESS-STANDARD
Bromsitetm (bromfenac ophthalmic Solution): Sun Pharma Global v. Lupin Limited
15 Feb 2018 //
PATENT LITIGATION
Sun Pharma to end patent litigation with Ironwood, Allergan in US
17 Jan 2018 //
BIOSPECTRUM
Sun Pharma buys bigger share of growing Malaysian venture
09 Jan 2018 //
FIERCE PHARMA
Nomura has this to say about Sun Pharma stock rating after US correction
04 Sep 2017 //
FINANCIALEXPRESS
Class-action lawsuits against Indian pharma companies on the rise
04 Sep 2017 //
BUSINESS-STANDARD
Sun Pharma receives USFDA nod for anti-cholesterol drug
15 Jun 2017 //
ECONOMIC TIMES
Sun Pharma shares soar on US FDA approval for generic Merck’s cholesterol drug
12 Jun 2017 //
FINANCIALEXPRESS
Why the Mayne Pharma Group Ltd share price is at a 52-week low
07 Jun 2017 //
FOOL
Sun Pharma, Torrent, DRL & Lupin CLSA’s top pharma picks
14 Apr 2017 //
ECONOMIC TIMES
Eliquis (Apixaban): Bristol-Myers Squibb & Pfizer v. Sun Pharmaceutical Industries
10 Apr 2017 //
PATENT LITIGATION
Dr. Reddy`s plant problems may derail launch of generic Glivec
09 Feb 2017 //
FIERCE PHARMA
Generics set to undercut blockbusters from Merck, Novartis and Bristol-Myers
18 Jan 2017 //
FIERCE PHARMA
Sun Pharma Announces Voluntary Withdrawal of 28 ANDAs
20 Dec 2016 //
ECONOMIC TIMES
The Top 100 Manufacturers Of Generic Pharmaceuticals Worldwide
16 Dec 2016 //
PR NEWSWIRE
Costco probed in Canada over alleged kickback scheme for generics
24 Nov 2016 //
STAT
US Probe Against Generic Drugs Overblown
08 Nov 2016 //
ECONOMIC TIMES
U.S. Charges in Generic-Drug Probe to Be Filed by Year-End
04 Nov 2016 //
BLOOMBERG
Sun Pharma launches generic versions of Daiichi`s high B.P drugs in US
28 Oct 2016 //
ECONOMIC TIMES
Pharma companies increase investments for global biosimilar push
24 Oct 2016 //
BUSINESS STANDARD
Generic Crestor market to become crowded in near future
23 May 2016 //
TWO FOUR INSIGHT
Generic Gleevec Will Hurt Novartis -- But Save Millions In Health Costs
17 Mar 2016 //
FORBES
Generic drug ETF ailing despite political focus on high drug prices
03 Mar 2016 //
REUTERS
Novartis expects India`s Sun to meet February U.S. generic Gleevec launch
28 Jan 2016 //
FIERCE PHARMA ASIA
Sun Pharma may earn $250-300 million in six months from Gleevec generic
05 Dec 2015 //
BUSINESS TODAY
How faster USFDA nods will help Indian generic drug makers
31 Aug 2015 //
THE ECONOMIC TIMES
Generics maker Alvogen eyes faster growth after CVC-led buyout
22 Jun 2015 //
FIERCE PHARMA
DoP rejects Ranbaxy`s review petition against fixation of ceiling prices of ciprofloxacin HCl injection
26 May 2015 //
PHARMABIZ.COM
How Much?! Teva Agrees to Pay $512M to Settle a Pay-to-Delay Case
21 Apr 2015 //
PHARMALOT
FDA Provides Generic Approval Roadmap for 38 Drugs, Including Vertex`s Kaldeco
11 Mar 2015 //
RAPS
